ROADZEN INC. Research and Development Expense
ROADZEN INC. (RDZN) reported Research and Development Expense of $419.12 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- ROADZEN INC. research and development expense for the quarter ending 2026-06-30 was $419.12K, a 414.04% increase year-over-year.
- ROADZEN INC. research and development expense for the quarter ending 2026-03-31 was -$115.66K, a 147.37% decline year-over-year.
- ROADZEN INC. research and development expense for the quarter ending 2025-12-31 was $293.96K, a 17.75% increase year-over-year.
- ROADZEN INC. research and development expense for the quarter ending 2025-09-30 was $148.53K, a 90.08% decline year-over-year.
- ROADZEN INC. research and development expense for fiscal 2026 was $408.36K, a 89.20% decline from fiscal 2025.
- ROADZEN INC. research and development expense for fiscal 2025 was $3.78M, a 24.00% decline from fiscal 2024.
- ROADZEN INC. research and development expense for fiscal 2024 was $4.97M, a 86.26% increase from fiscal 2023.
- ROADZEN INC. research and development expense for fiscal 2023 was $2.67M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $419.12K 10-Q · filed 2026-08-13 | $303.45K derived: sum of 2 quarters · filed 2026-08-13 | $597.41K derived: sum of 3 quarters · filed 2026-08-13 | $745.94K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$115.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $178.29K derived: sum of 2 quarters · filed 2026-06-29 | $326.82K derived: sum of 3 quarters · filed 2026-06-29 | $408.36K 10-K · filed 2026-06-29 |
| 2025-12-31 | $293.96K 10-Q · filed 2026-02-12 | $442.49K derived: sum of 2 quarters · filed 2026-02-12 | $524.02K 10-Q · filed 2026-02-12 | $768.20K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $148.53K 10-Q · filed 2025-11-14 | $230.06K 10-Q · filed 2025-11-14 | $474.24K derived: sum of 3 quarters · filed 2026-08-13 | $723.88K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $81.53K 10-Q · filed 2026-08-13 | $325.71K derived: sum of 2 quarters · filed 2026-08-13 | $575.35K derived: sum of 3 quarters · filed 2026-08-13 | $2.07M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $244.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $493.81K derived: sum of 2 quarters · filed 2026-06-29 | $1.99M derived: sum of 3 quarters · filed 2026-06-29 | $3.78M 10-K · filed 2026-06-29 |
| 2024-12-31 | $249.63K 10-Q · filed 2026-02-12 | $1.75M derived: sum of 2 quarters · filed 2026-02-12 | $3.54M 10-Q · filed 2026-02-12 | $5.46M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $1.50M 10-Q · filed 2025-11-14 | $3.29M 10-Q · filed 2025-11-14 | $5.21M derived: sum of 3 quarters · filed 2025-11-14 | $7.08M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.79M 10-Q · filed 2025-08-13 | $3.71M derived: sum of 2 quarters · filed 2025-08-13 | $5.59M derived: sum of 3 quarters · filed 2025-08-13 | $6.19M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-26 | $3.80M derived: sum of 2 quarters · filed 2025-06-26 | $4.40M derived: sum of 3 quarters · filed 2025-06-26 | $4.97M 10-K · filed 2025-06-26 |
| 2023-12-31 | $1.88M 10-Q · filed 2025-02-12 | $2.48M derived: sum of 2 quarters · filed 2025-02-12 | $3.05M 10-Q · filed 2025-02-12 | $3.94M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $602.11K 10-Q · filed 2024-11-13 | $1.18M 10-Q · filed 2024-11-13 | $2.07M derived: sum of 3 quarters · filed 2024-11-13 | $2.59M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $573.30K 10-Q · filed 2024-08-13 | $1.46M derived: sum of 2 quarters · filed 2024-08-13 | $1.98M derived: sum of 3 quarters · filed 2024-08-13 | $2.62M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $890.49K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-01 | $1.41M derived: sum of 2 quarters · filed 2024-07-01 | $2.05M derived: sum of 3 quarters · filed 2024-07-01 | $2.67M 10-K · filed 2024-07-01 |
| 2022-12-31 | $519.93K 10-Q · filed 2024-02-12 | $1.16M derived: sum of 2 quarters · filed 2024-02-12 | $1.78M 10-Q · filed 2024-02-12 | |
| 2022-09-30 | $638.45K 10-Q · filed 2023-11-13 | $1.26M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SelectQuote, Inc. (SLQT) | United States | $0.073B | 2.34 |
| eHealth, Inc. (EHTH) | United States | $0.026B | 1.75 |
| Reliance Global Group, Inc. (EZRA) | United States | $0.003B | |
| Goosehead Insurance, Inc. (GSHD) | United States | $0.922B | 276.12 |
| Baldwin Insurance Group, Inc. (BWIN) | United States | $1.083B | -498.48 |
| CORVEL CORP (CRVL) | United States | $3.727B | 27.41 |
| RYAN SPECIALTY HOLDINGS, INC. (RYAN) | United States | $4.038B | 67.32 |
| Equitable Holdings, Inc. (EQH) | United States | $14.367B | -12.94 |
| BROWN & BROWN, INC. (BRO) | United States | $20.190B | 17.57 |
| WILLIS TOWERS WATSON PLC (WTW) | $27.268B | 15.77 |